Clinical Trials
37 trialsBreath Analysis Based Disease Biomarkers
Mayo Clinic
Biliary Anastomosis Using Surgical Loupe Versus Microscope in Living Donor Liver Transplantation
Istanbul Medipol University Hospital
RCT of Screening Strategies Among Patients at High Risk for Developing HCC in a Safety-net Health System
University of Texas Southwestern Medical Center
TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA.
Boston Scientific Corporation
Safety and Effectiveness of Eye90 Microspheres™ in the Treatment of Unresectable Hepatocellular Carcinoma (HCC) and Metastatic Colorectal Cancer (mCRC)
ABK Biomedical
A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Hepatic Impairment
Taiho Oncology, Inc.
OPTIMA
Imunon
HEPATIC
Helio Genomics
TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC
Sichuan Cancer Hospital and Research Institute
A Phase 1 Study of Fisogatinib (BLU-554) in Patients With Hepatocellular Carcinoma
Blueprint Medicines Corporation
Lenvatinib Combined Anti-PD1 Antibody for the Advanced Hepatocellular Carcinoma
Sun Yat-sen University
MWA
Wake Forest University Health Sciences
Screening of Postoperative Pulmonary Complications by Electrical Impedance Tomography
Johannes Gutenberg University Mainz
Rapid 10-Minute Liver MRI Protocol in Patients With Suspected Hepatocellular Carcinoma
University of Nebraska
Low-dose Y90 Treatment Planning for HCC
Emory University
COVID19-FOIE National Observatory
Assistance Publique - HĂ´pitaux de Paris
Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular Cancer
H. Lee Moffitt Cancer Center and Research Institute
Magnetic Resonance Elastography and 2-Point Dixon MR Imaging Techniques in Diffuse Liver Disease
M.D. Anderson Cancer Center
ESCULAP
University Hospital Erlangen
A Study Of Avelumab In Combination With Axitinib In Advanced HCC (VEGF Liver 100)
Pfizer
Evaluation of Liver Cancer With Magnetic Resonance Imaging (MRI)
Icahn School of Medicine at Mount Sinai
A2ALL-2
Arbor Research Collaborative for Health
A2ALL-Patients Safety System Improvements in Living Donor Liver Transplantation
Northwestern University
LiFE
Seoul National University Hospital
Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors
Yale University
Stratification of Patients With Chronic Liver Disease Using Multi Spectral CT
Massachusetts General Hospital
An Analysis of Urinary Proteases as Biomarkers for Hepatocellular Carcinoma-101423
Vanderbilt University Medical Center
The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital
ORANGE II
Maastricht University Medical Center
Quality of Life After Liver Resection
University of Bern
Change of Lactate Concentration During Hartmann Solution Infusion for Hepatic Resection
Samsung Medical Center
Study of IMC-1121B (Ramucirumab) in Participants With Liver Cancer Who Have Not Previously Been Treated With Chemotherapy
Eli Lilly and Company
Use of N-Acetylcysteine During Liver Procurement
Azienda Ospedaliera di Padova
A Pharmacodynamic Study of AV-299 (Formerly SCH 900105) in Subjects With Advanced Solid Tumors Who Have Liver Metastases
AVEO Pharmaceuticals, Inc.
Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy
M.D. Anderson Cancer Center
Estimation of Functional Liver Reserve Using Cholinesterases
University of Milan
Qidong Hepatitis B Intervention Study
University of Oxford